Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/1/10 → 4/30/14 |
Funding
- Arno Therapeutics Inc: $16,419.00
A Phase 2 Study of AR-67 (7-t-butyldimrthydiltyl-10-hydroxycamptothecin) in Adult Patients with Recurrence of Glioblastoma Multiforme (GBM) or Gliosarcoma
- Arnold, Susanne (PI)